337 related articles for article (PubMed ID: 26778409)
1. Cytotoxic polyfunctionality maturation of cytomegalovirus-pp65-specific CD4 + and CD8 + T-cell responses in older adults positively correlates with response size.
Chiu YL; Lin CH; Sung BY; Chuang YF; Schneck JP; Kern F; Pawelec G; Wang GC
Sci Rep; 2016 Jan; 6():19227. PubMed ID: 26778409
[TBL] [Abstract][Full Text] [Related]
2. Co-ordinated isolation of CD8(+) and CD4(+) T cells recognizing a broad repertoire of cytomegalovirus pp65 and IE1 epitopes for highly specific adoptive immunotherapy.
Zandvliet ML; van Liempt E; Jedema I; Veltrop-Duits LA; Willemze R; Guchelaar HJ; Falkenburg JH; Meij P
Cytotherapy; 2010 Nov; 12(7):933-44. PubMed ID: 20078388
[TBL] [Abstract][Full Text] [Related]
3. Influence of HIV infection on cytomegalovirus-specific immunity: T-cell responses to pp65 and IE1 before and after HAART may reflect altered cytomegalovirus biology.
Scherrenburg J; Schellens IM; van Baarle D
Antivir Ther; 2011; 16(4):565-75. PubMed ID: 21685544
[TBL] [Abstract][Full Text] [Related]
4. Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations.
Gratama JW; Brooimans RA; van der Holt B; Sintnicolaas K; van Doornum G; Niesters HG; Löwenberg B; Cornelissen JJ
Cytometry B Clin Cytom; 2008 Jul; 74(4):211-20. PubMed ID: 18454493
[TBL] [Abstract][Full Text] [Related]
5. Rapid generation of CMV pp65-specific T cells for immunotherapy.
Bao L; Sun Q; Lucas KG
J Immunother; 2007; 30(5):557-61. PubMed ID: 17589296
[TBL] [Abstract][Full Text] [Related]
6. Functional patterns of cytomegalovirus (CMV) pp65 and immediate early-1-specific CD8(+) T cells that are associated with protection from and control of CMV DNAemia after allogeneic stem cell transplantation.
Giménez E; Muñoz-Cobo B; Solano C; Amat P; de la Cámara R; Nieto J; López J; Remigia MJ; Garcia-Noblejas A; Navarro D
Transpl Infect Dis; 2015 Jun; 17(3):361-70. PubMed ID: 25850900
[TBL] [Abstract][Full Text] [Related]
7. T-bet:Eomes balance, effector function, and proliferation of cytomegalovirus-specific CD8+ T cells during primary infection differentiates the capacity for durable immune control.
Popescu I; Pipeling MR; Shah PD; Orens JB; McDyer JF
J Immunol; 2014 Dec; 193(11):5709-5722. PubMed ID: 25339676
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of Specific CD4+ and CD8+ T Cells Stimulated by CMV pp65 and IE1 Antigens.
Albiero E; Amati E; Baumeister E; Einsele H; Grigoleit GU; Rodeghiero F
J Immunother; 2016; 39(9):329-342. PubMed ID: 27631893
[TBL] [Abstract][Full Text] [Related]
9. Human bone marrow as a source to generate CMV-specific CD4+ T cells with multifunctional capacity.
Na IK; Letsch A; Guerreiro M; Bauer S; Noack I; Geginat J; Reinke P; Loesch M; Kienapfel H; Thiel E; Volk HD; Scheibenbogen C
J Immunother; 2009; 32(9):907-13. PubMed ID: 19816191
[TBL] [Abstract][Full Text] [Related]
10. Ex vivo stimulation and expansion of both CD4(+) and CD8(+) T cells from peripheral blood mononuclear cells of human cytomegalovirus-seropositive blood donors by using a soluble recombinant chimeric protein, IE1-pp65.
Vaz-Santiago J; Lulé J; Rohrlich P; Jacquier C; Gibert N; Le Roy E; Betbeder D; Davignon JL; Davrinche C
J Virol; 2001 Sep; 75(17):7840-7. PubMed ID: 11483727
[TBL] [Abstract][Full Text] [Related]
11. An optimized IFN-γ ELISpot assay for the sensitive and standardized monitoring of CMV protein-reactive effector cells of cell-mediated immunity.
Barabas S; Spindler T; Kiener R; Tonar C; Lugner T; Batzilla J; Bendfeldt H; Rascle A; Asbach B; Wagner R; Deml L
BMC Immunol; 2017 Mar; 18(1):14. PubMed ID: 28270111
[TBL] [Abstract][Full Text] [Related]
12. Cognate CD4 T-cell licensing of dendritic cells heralds anti-cytomegalovirus CD8 T-cell immunity after human allogeneic umbilical cord blood transplantation.
Flinsenberg TW; Spel L; Jansen M; Koning D; de Haar C; Plantinga M; Scholman R; van Loenen MM; Nierkens S; Boon L; van Baarle D; Heemskerk MH; Boelens JJ; Boes M
J Virol; 2015 Jan; 89(2):1058-69. PubMed ID: 25378489
[TBL] [Abstract][Full Text] [Related]
13. Functional profile of cytomegalovirus (CMV)-specific CD8+ T cells and kinetics of NKG2C+ NK cells associated with the resolution of CMV DNAemia in allogeneic stem cell transplant recipients.
Muñoz-Cobo B; Solano C; Benet I; Costa E; Remigia MJ; de la Cámara R; Nieto J; López J; Amat P; Garcia-Noblejas A; Bravo D; Clari MÁ; Navarro D
J Med Virol; 2012 Feb; 84(2):259-67. PubMed ID: 22170546
[TBL] [Abstract][Full Text] [Related]
14. Robust expansion of viral antigen-specific CD4+ and CD8+ T cells for adoptive T cell therapy using gene-modified activated T cells as antigen presenting cells.
Melenhorst JJ; Solomon SR; Shenoy A; Hensel NF; McCoy JP; Keyvanfar K; Barrett AJ
J Immunother; 2006; 29(4):436-43; discussion 365-6. PubMed ID: 16799339
[TBL] [Abstract][Full Text] [Related]
15. IFNγ⁻TNFα⁻IL2⁻MIP1α⁻CD107a⁺PRF1⁺ CD8 pp65-Specific T-Cell Response Is Independently Associated With Time to Death in Elderly Humans.
Ferrando-Martínez S; Ruiz-Mateos E; Casazza JP; de Pablo-Bernal RS; Dominguez-Molina B; Muñoz-Fernández MÁ; Delgado J; de la Rosa R; Solana R; Koup RA; Leal M
J Gerontol A Biol Sci Med Sci; 2015 Oct; 70(10):1210-8. PubMed ID: 25238774
[TBL] [Abstract][Full Text] [Related]
16. A canarypox vector-expressing cytomegalovirus (CMV) phosphoprotein 65 induces long-lasting cytotoxic T cell responses in human CMV-seronegative subjects.
Berencsi K; Gyulai Z; Gönczöl E; Pincus S; Cox WI; Michelson S; Kari L; Meric C; Cadoz M; Zahradnik J; Starr S; Plotkin S
J Infect Dis; 2001 Apr; 183(8):1171-9. PubMed ID: 11262198
[TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals.
Kern F; Bunde T; Faulhaber N; Kiecker F; Khatamzas E; Rudawski IM; Pruss A; Gratama JW; Volkmer-Engert R; Ewert R; Reinke P; Volk HD; Picker LJ
J Infect Dis; 2002 Jun; 185(12):1709-16. PubMed ID: 12085315
[TBL] [Abstract][Full Text] [Related]
18. Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells.
Bunde T; Kirchner A; Hoffmeister B; Habedank D; Hetzer R; Cherepnev G; Proesch S; Reinke P; Volk HD; Lehmkuhl H; Kern F
J Exp Med; 2005 Apr; 201(7):1031-6. PubMed ID: 15795239
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous activation of viral antigen-specific memory CD4+ and CD8+ T-cells using mRNA-electroporated CD40-activated autologous B-cells.
Van den Bosch GA; Van Gulck E; Ponsaerts P; Nijs G; Lenjou M; Apers L; Kint I; Heyndrickx L; Vanham G; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
J Immunother; 2006; 29(5):512-23. PubMed ID: 16971807
[TBL] [Abstract][Full Text] [Related]
20. Antigen-specific T cell responses induced by Towne cytomegalovirus (CMV) vaccine in CMV-seronegative vaccine recipients.
Jacobson MA; Sinclair E; Bredt B; Agrillo L; Black D; Epling CL; Carvidi A; Ho T; Bains R; Adler SP
J Clin Virol; 2006 Mar; 35(3):332-7. PubMed ID: 16387547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]